Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Corcept Therapeutics (CORT) over the last 13 years, with Q3 2025 value amounting to $0.19.

  • Corcept Therapeutics' EPS (Basic) fell 5777.78% to $0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0, marking a year-over-year decrease of 2647.06%. This contributed to the annual value of $1.35 for FY2024, which is 3270.41% up from last year.
  • Corcept Therapeutics' EPS (Basic) amounted to $0.19 in Q3 2025, which was down 5777.78% from $0.33 recorded in Q2 2025.
  • Over the past 5 years, Corcept Therapeutics' EPS (Basic) peaked at $0.45 during Q3 2024, and registered a low of $0.15 during Q4 2022.
  • Its 5-year average for EPS (Basic) is $0.26, with a median of $0.27 in 2023.
  • In the last 5 years, Corcept Therapeutics' EPS (Basic) skyrocketed by 10000.0% in 2023 and then crashed by 5777.78% in 2025.
  • Quarter analysis of 5 years shows Corcept Therapeutics' EPS (Basic) stood at $0.28 in 2021, then crashed by 46.43% to $0.15 in 2022, then skyrocketed by 100.0% to $0.3 in 2023, then fell by 1.87% to $0.29 in 2024, then tumbled by 35.46% to $0.19 in 2025.
  • Its last three reported values are $0.19 in Q3 2025, $0.33 for Q2 2025, and $0.19 during Q1 2025.